Stay updated on HMPL-504 in Lung Sarcomatoid Carcinoma Clinical Trial
Sign up to get notified when there's something new on the HMPL-504 in Lung Sarcomatoid Carcinoma Clinical Trial page.

Latest updates to the HMPL-504 in Lung Sarcomatoid Carcinoma Clinical Trial page
- Check6 days agoChange DetectedThe study page now displays the Phase II savolitinib trial record for patients with MET Exon 14–positive lung cancer, including its design, participant criteria, study locations, and measured outcomes.SummaryDifference37%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedAn NIH notice about website terminology appears above the existing 403 error page, and the site revision identifier is updated.SummaryDifference1%

- Check33 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error page instead of the study record, indicating an access restriction or server issue preventing loading the NCT02897479 entry.SummaryDifference16%

- Check61 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0, indicating a deployment or template update; no study content or data appears to have changed.SummaryDifference0.1%

Stay in the know with updates to HMPL-504 in Lung Sarcomatoid Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-504 in Lung Sarcomatoid Carcinoma Clinical Trial page.